REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Synbone Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical Preparation Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Synbone Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

To designs, develops, produce, sells and distributes artifical bones and anatomical models for research, education and promotion in the medical forensic field

Headquarters
No. 40-41, Jalan I-Park 1/3, Kawasan Perindustrian I-Park, Bandar Indahpura
Kulai; Johor; Postal Code: 81000

Contact Details: Purchase the Synbone Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Synbone Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Synbone Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Synbone Sdn. Bhd. report to view the information.
Incorporation Date:
March 05, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Synbone Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
40.95%▲
Total operating revenue
40.95%▲
Operating profit (EBIT)
53.12%▲
EBITDA
65.2%▲
Net Profit (Loss) for the Period
53.12%▲
Total assets
-4.75%▼
Total equity
-17.02%▼
Operating Profit Margin (ROS)
45.68%▲
Net Profit Margin
45.68%▲
Return on Equity (ROE)
-21.67%▼
Debt to Equity Ratio
12.08%▲
Quick Ratio
-0.05%▼
Cash Ratio
-0.05%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo